NCT01067482

Brief Summary

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 11, 2010

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

March 23, 2010

Status Verified

October 1, 2009

Enrollment Period

6 months

First QC Date

February 10, 2010

Last Update Submit

March 22, 2010

Conditions

Glaucoma PatientGlaucoma Suspect PatientNormal PopulationRNFL Thickness by LocationMacular Thickness by Location

Keywords

OCTspectral domain cirrusglaucomaglaucoma suspectnormal population

Study Arms (3)

Glaucoma patients

Glaucoma suspect group

Normal population

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

glaucoma patient from glaucoma clinic that is POAG Glaucoma suspect cases normal population case

You may qualify if:

  • BCVA at least 20/60
  • refractive error +/- 5 D Or astig +/- 3 D
  • enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

You may not qualify if:

  • VA less than 20/60
  • marked RF error
  • previous ocular trauma or surgery
  • unreliable visual field
  • poor signal cirrus OCT (less than 7)
  • other causes of optic nerve or macular disease other than glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University

Hat Yai, Songkhla, Thailand., 90110, Thailand

Location

MeSH Terms

Conditions

GlaucomaOcular Hypertension

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Weerawat Kiddee, MD

    Prince of Songkla University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 10, 2010

First Posted

February 11, 2010

Study Start

September 1, 2009

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

March 23, 2010

Record last verified: 2009-10

Locations

TH(1)